2021 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 176 % |
Worst rating | -2,050 % |
New companies | 6 |
Negative Economic Capital Ratio | 17 of 52 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 176 % |
Worst rating | -2,050 % |
New companies | 6 |
Negative Economic Capital Ratio | 17 of 52 |
ARCA biopharma Inc. climbed 23 positions from 30 to 7 due to its excellent Assets, Current.Pure Harvest Corporate Group Inc. lost 18 positions from 19 to 37 due to its bad Revenues.Canopy Growth Corp entered the 2021 ranking at rank 16, making it the best newcomer.
Revenues | 34.1 B |
Assets | 65.7 B |
Expenses | 35.7 B |
Stockholders Equity | 30.1 B |
Unprofitable Companies | 38 of 52 |
Some amazing news from RealRate today! A video from Holger Bartel, our esteemed [...]
Source: https://openai.com/dall-e-3/ We are extremely excited to announce that RealRate’s first ranking [...]
We’re thrilled to have participated in the TDWI
RealRate is excited to announce that the new 2024 ratings are coming very [...]
We are extremely excited to announce that an interview with Holger Bartel has [...]
On February 14th, 2024, something momentous happened. Nvidia, the chip and graphics card [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Pharma are [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Savings are [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai